Neoadjuvant Dose-Dense For Early Her2Neu Positive Breast Cancer
Clinical trial NCT03329378 · TERMINATED
Trial details
- NCT number
- NCT03329378
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-24
- Primary completion
- 2021-03-07
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.